Aspen Pharmacare reported ZAR9.63B in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Aspen Pharmacare ZAR 9.63B 3.1B Dec/2025
Cipla INR 26.32B 2.79B Mar/2026
Dr.Reddys Laboratories INR 37.7B 1.54B Mar/2026
Jiangsu Hengrui CNY 1.09B 76.27M Mar/2026
Kalbe Farma IDR 5.46T 523.94B Sep/2025
Life Healthcare ZAR 9B 382M Jun/2026
Netcare ZAR 6.89B 536M Dec/2025
Richter Gedeon HUF 72.45B 1.13B Mar/2026